An Evaluation of the Stemness, Paracrine, and Tumorigenic Characteristics of Highly Expanded, Minimally Passaged Adipose-Derived Stem Cells

The use of adipose-derived stem cells (ADSC) in regenerative medicine is rising due to their plasticity, capacity of differentiation and paracrine and trophic effects. Despite the large number of cells obtained from adipose tissue, it is usually not enough for therapeutic purposes for many diseases...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2016-09, Vol.11 (9), p.e0162332
Hauptverfasser: El Atat, Oula, Antonios, Diane, Hilal, George, Hokayem, Nabil, Abou-Ghoch, Joelle, Hashim, Hussein, Serhal, Rim, Hebbo, Clara, Moussa, Mayssam, Alaaeddine, Nada
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 9
container_start_page e0162332
container_title PloS one
container_volume 11
creator El Atat, Oula
Antonios, Diane
Hilal, George
Hokayem, Nabil
Abou-Ghoch, Joelle
Hashim, Hussein
Serhal, Rim
Hebbo, Clara
Moussa, Mayssam
Alaaeddine, Nada
description The use of adipose-derived stem cells (ADSC) in regenerative medicine is rising due to their plasticity, capacity of differentiation and paracrine and trophic effects. Despite the large number of cells obtained from adipose tissue, it is usually not enough for therapeutic purposes for many diseases or cosmetic procedures. Thus, there is the need for culturing and expanding cells in-vitro for several weeks remain. Our aim is to investigate if long- term proliferation with minimal passaging will affect the stemness, paracrine secretions and carcinogenesis markers of ADSC. The immunophenotypic properties and aldehyde dehydrogenase (ALDH) activity of the initial stromal vascular fraction (SVF) and serially passaged ADSC were observed by flow cytometry. In parallel, the telomerase activity and the relative expression of oncogenes and tumor suppressor genes were assessed by q-PCR. We also assessed the cytokine secretion profile of passaged ADSC by an ELISA. The expanded ADSC retain their morphological and phenotypical characteristics. These cells maintained in culture for up to 12 weeks until P4, possessed stable telomerase and ALDH activity, without having a TP53 mutation. Furthermore, the relative expression levels of TP53, RB, and MDM2 were not affected while the relative expression of c-Myc decreased significantly. Finally, the levels of the secretions of PGE2, STC1, and TIMP2 were not affected but the levels of IL-6, VEGF, and TIMP 1 significantly decreased at P2. Our results suggest that the expansion of passaged ADSC does not affect the differentiation capacity of stem cells and does not confer a cancerous state or capacity in vitro to the cells.
doi_str_mv 10.1371/journal.pone.0162332
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1819907456</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A470941224</galeid><doaj_id>oai_doaj_org_article_23c5c6ff08f349a2bda96459ae4a1a11</doaj_id><sourcerecordid>A470941224</sourcerecordid><originalsourceid>FETCH-LOGICAL-c725t-fd8ac7380d3ed5d843a7ddaeafccc3743835bf1d83aabea126461fcdd93f20513</originalsourceid><addsrcrecordid>eNqNk99u0zAUxiMEYmPwBggiTUIgtSW28_cGqSqFVRraxAa31ql9nHpK7GIn1fYMvDQO7aYW7QLlIvHx7_uOz4lPFL0myYSwgny8sb0z0EzW1uAkITlljD6JjknF6DinCXu6930UvfD-JkkyVub58-iIFjmjYXEc_Z6aeL6BpodOWxNbFXcrjK86bA16P4ovwYFw2uAoBiPj6761TtdotIhnq2GvQ6d9p4UftGe6XjV38fx2HWCUo_ibNrqFJsQuwXuoUcZTqdfW4_hzEG7CesgVz7Bp_MvomYLG46vd-yT68WV-PTsbn198Xcym52NR0KwbK1mCKFiZSIYyk2XKoJASEJQQghUpK1m2VESWDGCJQGie5kQJKSumaJIRdhK93fquG-v5ro-ek5JUVVKkWR6IxZaQFm742oUa3B23oPnfgHU1BxeKbpBTJjKRK5WUiqUV0KWEKk-zCjAFAmTI9mmXrV-2KAWazkFzYHq4Y_SK13bDs4SmVTUYvN8ZOPurR9_xVnsRGgYGbT-cmxZlyVhWBvT0H_Tx6nZUDaEAbZQNecVgyqdpkVQpoTQN1OQRKjwSWy3CpVM6xA8EHw4Egenwtquh954vrr7_P3vx85B9t8euEJpu5W3TDxfWH4LpFhTOeu9QPTSZJHyYmftu8GFm-G5mguzN_g96EN0PCfsDqg4TKA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1819907456</pqid></control><display><type>article</type><title>An Evaluation of the Stemness, Paracrine, and Tumorigenic Characteristics of Highly Expanded, Minimally Passaged Adipose-Derived Stem Cells</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>El Atat, Oula ; Antonios, Diane ; Hilal, George ; Hokayem, Nabil ; Abou-Ghoch, Joelle ; Hashim, Hussein ; Serhal, Rim ; Hebbo, Clara ; Moussa, Mayssam ; Alaaeddine, Nada</creator><creatorcontrib>El Atat, Oula ; Antonios, Diane ; Hilal, George ; Hokayem, Nabil ; Abou-Ghoch, Joelle ; Hashim, Hussein ; Serhal, Rim ; Hebbo, Clara ; Moussa, Mayssam ; Alaaeddine, Nada</creatorcontrib><description>The use of adipose-derived stem cells (ADSC) in regenerative medicine is rising due to their plasticity, capacity of differentiation and paracrine and trophic effects. Despite the large number of cells obtained from adipose tissue, it is usually not enough for therapeutic purposes for many diseases or cosmetic procedures. Thus, there is the need for culturing and expanding cells in-vitro for several weeks remain. Our aim is to investigate if long- term proliferation with minimal passaging will affect the stemness, paracrine secretions and carcinogenesis markers of ADSC. The immunophenotypic properties and aldehyde dehydrogenase (ALDH) activity of the initial stromal vascular fraction (SVF) and serially passaged ADSC were observed by flow cytometry. In parallel, the telomerase activity and the relative expression of oncogenes and tumor suppressor genes were assessed by q-PCR. We also assessed the cytokine secretion profile of passaged ADSC by an ELISA. The expanded ADSC retain their morphological and phenotypical characteristics. These cells maintained in culture for up to 12 weeks until P4, possessed stable telomerase and ALDH activity, without having a TP53 mutation. Furthermore, the relative expression levels of TP53, RB, and MDM2 were not affected while the relative expression of c-Myc decreased significantly. Finally, the levels of the secretions of PGE2, STC1, and TIMP2 were not affected but the levels of IL-6, VEGF, and TIMP 1 significantly decreased at P2. Our results suggest that the expansion of passaged ADSC does not affect the differentiation capacity of stem cells and does not confer a cancerous state or capacity in vitro to the cells.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0162332</identifier><identifier>PMID: 27632538</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adipocytes ; Adipose tissue ; Adipose Tissue - cytology ; Adipose Tissue - immunology ; Adolescent ; Adult ; Aldehyde dehydrogenase ; Aldehyde Dehydrogenase - metabolism ; Analysis ; Apoptosis ; Biology and Life Sciences ; Bone marrow ; c-Myc protein ; Cancer ; Carcinogenesis ; Carcinogens ; Cell culture ; Cell Differentiation ; Cell Lineage ; Cytometry ; Dehydrogenases ; Dermatology ; Diabetes ; Differentiation ; Enzyme-linked immunosorbent assay ; Fibroblasts ; Flow cytometry ; Gene expression ; Health aspects ; Humans ; Immunophenotyping ; Inflammation ; Interleukin 6 ; Kinases ; Laboratories ; MDM2 protein ; Medicine ; Medicine and Health Sciences ; Mesenchymal stem cells ; Middle Aged ; Mutation ; Myc protein ; p53 Protein ; Paracrine signalling ; Physical characteristics ; Plastic surgery ; Prostaglandin E2 ; Regenerative medicine ; Research and Analysis Methods ; Secretions ; Stem cells ; Stem Cells - cytology ; Stem Cells - immunology ; Telomerase ; Telomerase - metabolism ; Therapeutic applications ; Tissue engineering ; Tissue inhibitor of metalloproteinase 2 ; Tumor proteins ; Tumor suppressor genes ; Tumor Suppressor Protein p53 - metabolism ; Vascular endothelial growth factor ; Young Adult</subject><ispartof>PloS one, 2016-09, Vol.11 (9), p.e0162332</ispartof><rights>COPYRIGHT 2016 Public Library of Science</rights><rights>2016 El Atat et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2016 El Atat et al 2016 El Atat et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c725t-fd8ac7380d3ed5d843a7ddaeafccc3743835bf1d83aabea126461fcdd93f20513</citedby><cites>FETCH-LOGICAL-c725t-fd8ac7380d3ed5d843a7ddaeafccc3743835bf1d83aabea126461fcdd93f20513</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024991/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024991/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79342,79343</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27632538$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>El Atat, Oula</creatorcontrib><creatorcontrib>Antonios, Diane</creatorcontrib><creatorcontrib>Hilal, George</creatorcontrib><creatorcontrib>Hokayem, Nabil</creatorcontrib><creatorcontrib>Abou-Ghoch, Joelle</creatorcontrib><creatorcontrib>Hashim, Hussein</creatorcontrib><creatorcontrib>Serhal, Rim</creatorcontrib><creatorcontrib>Hebbo, Clara</creatorcontrib><creatorcontrib>Moussa, Mayssam</creatorcontrib><creatorcontrib>Alaaeddine, Nada</creatorcontrib><title>An Evaluation of the Stemness, Paracrine, and Tumorigenic Characteristics of Highly Expanded, Minimally Passaged Adipose-Derived Stem Cells</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>The use of adipose-derived stem cells (ADSC) in regenerative medicine is rising due to their plasticity, capacity of differentiation and paracrine and trophic effects. Despite the large number of cells obtained from adipose tissue, it is usually not enough for therapeutic purposes for many diseases or cosmetic procedures. Thus, there is the need for culturing and expanding cells in-vitro for several weeks remain. Our aim is to investigate if long- term proliferation with minimal passaging will affect the stemness, paracrine secretions and carcinogenesis markers of ADSC. The immunophenotypic properties and aldehyde dehydrogenase (ALDH) activity of the initial stromal vascular fraction (SVF) and serially passaged ADSC were observed by flow cytometry. In parallel, the telomerase activity and the relative expression of oncogenes and tumor suppressor genes were assessed by q-PCR. We also assessed the cytokine secretion profile of passaged ADSC by an ELISA. The expanded ADSC retain their morphological and phenotypical characteristics. These cells maintained in culture for up to 12 weeks until P4, possessed stable telomerase and ALDH activity, without having a TP53 mutation. Furthermore, the relative expression levels of TP53, RB, and MDM2 were not affected while the relative expression of c-Myc decreased significantly. Finally, the levels of the secretions of PGE2, STC1, and TIMP2 were not affected but the levels of IL-6, VEGF, and TIMP 1 significantly decreased at P2. Our results suggest that the expansion of passaged ADSC does not affect the differentiation capacity of stem cells and does not confer a cancerous state or capacity in vitro to the cells.</description><subject>Adipocytes</subject><subject>Adipose tissue</subject><subject>Adipose Tissue - cytology</subject><subject>Adipose Tissue - immunology</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aldehyde dehydrogenase</subject><subject>Aldehyde Dehydrogenase - metabolism</subject><subject>Analysis</subject><subject>Apoptosis</subject><subject>Biology and Life Sciences</subject><subject>Bone marrow</subject><subject>c-Myc protein</subject><subject>Cancer</subject><subject>Carcinogenesis</subject><subject>Carcinogens</subject><subject>Cell culture</subject><subject>Cell Differentiation</subject><subject>Cell Lineage</subject><subject>Cytometry</subject><subject>Dehydrogenases</subject><subject>Dermatology</subject><subject>Diabetes</subject><subject>Differentiation</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Fibroblasts</subject><subject>Flow cytometry</subject><subject>Gene expression</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Immunophenotyping</subject><subject>Inflammation</subject><subject>Interleukin 6</subject><subject>Kinases</subject><subject>Laboratories</subject><subject>MDM2 protein</subject><subject>Medicine</subject><subject>Medicine and Health Sciences</subject><subject>Mesenchymal stem cells</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Myc protein</subject><subject>p53 Protein</subject><subject>Paracrine signalling</subject><subject>Physical characteristics</subject><subject>Plastic surgery</subject><subject>Prostaglandin E2</subject><subject>Regenerative medicine</subject><subject>Research and Analysis Methods</subject><subject>Secretions</subject><subject>Stem cells</subject><subject>Stem Cells - cytology</subject><subject>Stem Cells - immunology</subject><subject>Telomerase</subject><subject>Telomerase - metabolism</subject><subject>Therapeutic applications</subject><subject>Tissue engineering</subject><subject>Tissue inhibitor of metalloproteinase 2</subject><subject>Tumor proteins</subject><subject>Tumor suppressor genes</subject><subject>Tumor Suppressor Protein p53 - metabolism</subject><subject>Vascular endothelial growth factor</subject><subject>Young Adult</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNk99u0zAUxiMEYmPwBggiTUIgtSW28_cGqSqFVRraxAa31ql9nHpK7GIn1fYMvDQO7aYW7QLlIvHx7_uOz4lPFL0myYSwgny8sb0z0EzW1uAkITlljD6JjknF6DinCXu6930UvfD-JkkyVub58-iIFjmjYXEc_Z6aeL6BpodOWxNbFXcrjK86bA16P4ovwYFw2uAoBiPj6761TtdotIhnq2GvQ6d9p4UftGe6XjV38fx2HWCUo_ibNrqFJsQuwXuoUcZTqdfW4_hzEG7CesgVz7Bp_MvomYLG46vd-yT68WV-PTsbn198Xcym52NR0KwbK1mCKFiZSIYyk2XKoJASEJQQghUpK1m2VESWDGCJQGie5kQJKSumaJIRdhK93fquG-v5ro-ek5JUVVKkWR6IxZaQFm742oUa3B23oPnfgHU1BxeKbpBTJjKRK5WUiqUV0KWEKk-zCjAFAmTI9mmXrV-2KAWazkFzYHq4Y_SK13bDs4SmVTUYvN8ZOPurR9_xVnsRGgYGbT-cmxZlyVhWBvT0H_Tx6nZUDaEAbZQNecVgyqdpkVQpoTQN1OQRKjwSWy3CpVM6xA8EHw4Egenwtquh954vrr7_P3vx85B9t8euEJpu5W3TDxfWH4LpFhTOeu9QPTSZJHyYmftu8GFm-G5mguzN_g96EN0PCfsDqg4TKA</recordid><startdate>20160915</startdate><enddate>20160915</enddate><creator>El Atat, Oula</creator><creator>Antonios, Diane</creator><creator>Hilal, George</creator><creator>Hokayem, Nabil</creator><creator>Abou-Ghoch, Joelle</creator><creator>Hashim, Hussein</creator><creator>Serhal, Rim</creator><creator>Hebbo, Clara</creator><creator>Moussa, Mayssam</creator><creator>Alaaeddine, Nada</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20160915</creationdate><title>An Evaluation of the Stemness, Paracrine, and Tumorigenic Characteristics of Highly Expanded, Minimally Passaged Adipose-Derived Stem Cells</title><author>El Atat, Oula ; Antonios, Diane ; Hilal, George ; Hokayem, Nabil ; Abou-Ghoch, Joelle ; Hashim, Hussein ; Serhal, Rim ; Hebbo, Clara ; Moussa, Mayssam ; Alaaeddine, Nada</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c725t-fd8ac7380d3ed5d843a7ddaeafccc3743835bf1d83aabea126461fcdd93f20513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adipocytes</topic><topic>Adipose tissue</topic><topic>Adipose Tissue - cytology</topic><topic>Adipose Tissue - immunology</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aldehyde dehydrogenase</topic><topic>Aldehyde Dehydrogenase - metabolism</topic><topic>Analysis</topic><topic>Apoptosis</topic><topic>Biology and Life Sciences</topic><topic>Bone marrow</topic><topic>c-Myc protein</topic><topic>Cancer</topic><topic>Carcinogenesis</topic><topic>Carcinogens</topic><topic>Cell culture</topic><topic>Cell Differentiation</topic><topic>Cell Lineage</topic><topic>Cytometry</topic><topic>Dehydrogenases</topic><topic>Dermatology</topic><topic>Diabetes</topic><topic>Differentiation</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Fibroblasts</topic><topic>Flow cytometry</topic><topic>Gene expression</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Immunophenotyping</topic><topic>Inflammation</topic><topic>Interleukin 6</topic><topic>Kinases</topic><topic>Laboratories</topic><topic>MDM2 protein</topic><topic>Medicine</topic><topic>Medicine and Health Sciences</topic><topic>Mesenchymal stem cells</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Myc protein</topic><topic>p53 Protein</topic><topic>Paracrine signalling</topic><topic>Physical characteristics</topic><topic>Plastic surgery</topic><topic>Prostaglandin E2</topic><topic>Regenerative medicine</topic><topic>Research and Analysis Methods</topic><topic>Secretions</topic><topic>Stem cells</topic><topic>Stem Cells - cytology</topic><topic>Stem Cells - immunology</topic><topic>Telomerase</topic><topic>Telomerase - metabolism</topic><topic>Therapeutic applications</topic><topic>Tissue engineering</topic><topic>Tissue inhibitor of metalloproteinase 2</topic><topic>Tumor proteins</topic><topic>Tumor suppressor genes</topic><topic>Tumor Suppressor Protein p53 - metabolism</topic><topic>Vascular endothelial growth factor</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>El Atat, Oula</creatorcontrib><creatorcontrib>Antonios, Diane</creatorcontrib><creatorcontrib>Hilal, George</creatorcontrib><creatorcontrib>Hokayem, Nabil</creatorcontrib><creatorcontrib>Abou-Ghoch, Joelle</creatorcontrib><creatorcontrib>Hashim, Hussein</creatorcontrib><creatorcontrib>Serhal, Rim</creatorcontrib><creatorcontrib>Hebbo, Clara</creatorcontrib><creatorcontrib>Moussa, Mayssam</creatorcontrib><creatorcontrib>Alaaeddine, Nada</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>El Atat, Oula</au><au>Antonios, Diane</au><au>Hilal, George</au><au>Hokayem, Nabil</au><au>Abou-Ghoch, Joelle</au><au>Hashim, Hussein</au><au>Serhal, Rim</au><au>Hebbo, Clara</au><au>Moussa, Mayssam</au><au>Alaaeddine, Nada</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An Evaluation of the Stemness, Paracrine, and Tumorigenic Characteristics of Highly Expanded, Minimally Passaged Adipose-Derived Stem Cells</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2016-09-15</date><risdate>2016</risdate><volume>11</volume><issue>9</issue><spage>e0162332</spage><pages>e0162332-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>The use of adipose-derived stem cells (ADSC) in regenerative medicine is rising due to their plasticity, capacity of differentiation and paracrine and trophic effects. Despite the large number of cells obtained from adipose tissue, it is usually not enough for therapeutic purposes for many diseases or cosmetic procedures. Thus, there is the need for culturing and expanding cells in-vitro for several weeks remain. Our aim is to investigate if long- term proliferation with minimal passaging will affect the stemness, paracrine secretions and carcinogenesis markers of ADSC. The immunophenotypic properties and aldehyde dehydrogenase (ALDH) activity of the initial stromal vascular fraction (SVF) and serially passaged ADSC were observed by flow cytometry. In parallel, the telomerase activity and the relative expression of oncogenes and tumor suppressor genes were assessed by q-PCR. We also assessed the cytokine secretion profile of passaged ADSC by an ELISA. The expanded ADSC retain their morphological and phenotypical characteristics. These cells maintained in culture for up to 12 weeks until P4, possessed stable telomerase and ALDH activity, without having a TP53 mutation. Furthermore, the relative expression levels of TP53, RB, and MDM2 were not affected while the relative expression of c-Myc decreased significantly. Finally, the levels of the secretions of PGE2, STC1, and TIMP2 were not affected but the levels of IL-6, VEGF, and TIMP 1 significantly decreased at P2. Our results suggest that the expansion of passaged ADSC does not affect the differentiation capacity of stem cells and does not confer a cancerous state or capacity in vitro to the cells.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>27632538</pmid><doi>10.1371/journal.pone.0162332</doi><tpages>e0162332</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2016-09, Vol.11 (9), p.e0162332
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1819907456
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS)
subjects Adipocytes
Adipose tissue
Adipose Tissue - cytology
Adipose Tissue - immunology
Adolescent
Adult
Aldehyde dehydrogenase
Aldehyde Dehydrogenase - metabolism
Analysis
Apoptosis
Biology and Life Sciences
Bone marrow
c-Myc protein
Cancer
Carcinogenesis
Carcinogens
Cell culture
Cell Differentiation
Cell Lineage
Cytometry
Dehydrogenases
Dermatology
Diabetes
Differentiation
Enzyme-linked immunosorbent assay
Fibroblasts
Flow cytometry
Gene expression
Health aspects
Humans
Immunophenotyping
Inflammation
Interleukin 6
Kinases
Laboratories
MDM2 protein
Medicine
Medicine and Health Sciences
Mesenchymal stem cells
Middle Aged
Mutation
Myc protein
p53 Protein
Paracrine signalling
Physical characteristics
Plastic surgery
Prostaglandin E2
Regenerative medicine
Research and Analysis Methods
Secretions
Stem cells
Stem Cells - cytology
Stem Cells - immunology
Telomerase
Telomerase - metabolism
Therapeutic applications
Tissue engineering
Tissue inhibitor of metalloproteinase 2
Tumor proteins
Tumor suppressor genes
Tumor Suppressor Protein p53 - metabolism
Vascular endothelial growth factor
Young Adult
title An Evaluation of the Stemness, Paracrine, and Tumorigenic Characteristics of Highly Expanded, Minimally Passaged Adipose-Derived Stem Cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T04%3A09%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20Evaluation%20of%20the%20Stemness,%20Paracrine,%20and%20Tumorigenic%20Characteristics%20of%20Highly%20Expanded,%20Minimally%20Passaged%20Adipose-Derived%20Stem%20Cells&rft.jtitle=PloS%20one&rft.au=El%20Atat,%20Oula&rft.date=2016-09-15&rft.volume=11&rft.issue=9&rft.spage=e0162332&rft.pages=e0162332-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0162332&rft_dat=%3Cgale_plos_%3EA470941224%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1819907456&rft_id=info:pmid/27632538&rft_galeid=A470941224&rft_doaj_id=oai_doaj_org_article_23c5c6ff08f349a2bda96459ae4a1a11&rfr_iscdi=true